Journal of Medicinal Chemistry p. 1578 - 1585 (1994)
Update date:2022-09-26
Topics:
Archer
Seyed-Mozaffari
Jiang
Bidlack
14α,14'β-[Dithiobis[2-oxo-2,1-ethanediyl)imino]]bis(7,8- dihydromorphinone) (TAMO) (13) was synthesized by condensing 14β-amino-7,8- dihydromorphinone (4) with acetylthioglycolyl chloride and hydrolyzing the resulting ester with mild base to give a mixture of the thiol 9 and the disulfide 13. Chromatography of the mixture resulted in conversion of the bulk of the thiol 9 to the disulfide 13 by air oxidation. The disulfide 13 was also prepared by condensing the tert-butyldimethylsilyl ether of 4 with the dithiodiglycolyl chloride and treating the resulting product with F- to give the desired product. The pure thiol 9 free of contamination with the disulfide was prepared by treating 13 with excess N-acetyl-L-cysteine and processing the reaction mixture without resorting to chromatography for purification. The corresponding N-(cyclopropylmethyl) nor compound 15 was prepared from the silyl ether 6 and acetylthioglycolyl chloride followed by hydrolysis, treatment with F-, and air oxidation. Incubation of bovine striatal membranes with 13 and 15 resulted in wash-resistant inhibition of the binding of the μ-selective peptide[3H][D-Ala2,(Me)Phe4,Gly(ol)5]- enkephalin (DAMGO). Incubation of membranes with μ but not κ or δ ligands protected the μ binding sites from alkylation by 13 and 15. The wash- resistant inhibition of μ opioid binding was partially reversed by the addition of the reducing reagent dithiothreitol (DTT). A Scatchard plot of the effect of 13 and 15 on [3H]DAMGO binding showed that these affinity ligands caused a marked decrease in the B(max) value without affecting the K(d) value. The wash-resistant inhibition of binding, the reduction in the number of binding sites, the partial reversal of wash-resistant inhibition of binding by DTT, and previously observed long-term antagonism of μ opioid receptors in vivo support the conclusion that 13 and 15 bind covalently to the μ opioid receptor.
View MoreNanjing Norris Pharm Technology Co., Ltd.
Contact:+86-13901585132
Address:2 Qiande Road, Jiangning sciencepark Hi-Tech Zone, Nanjing, P.R.China
Hebei Lead Bio-Chemicals Co., Ltd.
website:http://www.ldbiochem.com
Contact:+86-311-87826503
Address:481, Heping West Road, Shijiazhuang,China
Kunshan Yalong Trading Co,.Ltd
Contact:86-512-57621185
Address:805-807 Room Hongqiao Mansion ,1088 West Qianjin Road, Kunshan, Jiangsu,China
Shanghai Forever Synthesis Co.,Ltd.
Contact:021-61124658
Address:Zhoukang Road,Pudong New District,Shanghai,China
Zhushan County Tianxin Pharmaceutical & Chemical Co., Ltd.
Contact:0086-719-4224892
Address:Tutang Road, Chengguan Town, Zhushan County, Hubei Province
Doi:10.1016/j.tet.2012.05.052
(2012)Doi:10.1021/acs.joc.0c00459
(2020)Doi:10.1039/c2cc34404a
(2012)Doi:10.1016/j.ejmech.2012.05.026
(2012)Doi:10.1002/hlca.201100481
(2012)Doi:10.1007/s12039-012-0258-9
(2012)